Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PLASTICAN

Financiado

Cerrado

Cell Plasticity in Metastatic Colorectal Cancer

Colorectal cancer (CRC) belongs to the most frequent tumor entities in both men and women. Although early detection and certain therapies have improved, the prognosis for patients with metastatic diseases is dismal and survival ra... ver más

31/12/2026

Georg-Speyer-Haus

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-12-06

ERC-2020-ADG: ERC ADVANCED GRANT

I+D

Cerrada hace 4 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

Georg-Speyer-Haus

2.50M€ | Lider

Proyectos interesantes

SAF2017-84976-R

Medical Technol...

Oncology

182K€ Cerrado

MetResistance

Medical Technol...

Applied Physics

1M€ Cerrado

BONEMETTNC

Medical Technol...

Applied Physics

100K€ Cerrado

SAF2016-76461-R

Medical Technol...

Cancer Research

424K€ Cerrado

CICCI

Medical Technol...

Applied Physics

183K€ Cerrado

BFU2015-73494-JIN

Medical Technol...

Applied Physics

194K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 60 meses Fecha Inicio: 2021-12-06
Fecha Fin: 2026-12-31

Líder del proyecto

CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Colorectal cancer (CRC) belongs to the most frequent tumor entities in both men and women. Although early detection and certain therapies have improved, the prognosis for patients with metastatic diseases is dismal and survival rates are below 10% at 5 years after diagnosis. Colorectal carcinogenesis is greatly dependent on the plasticity of both tumor cells as well as surrounding stromal cells within the tumor microenvironment. Among the latter, both T cells as well as mesenchymal cells substantially contribute to the survival prognosis. Importantly, mesenchymal cells are very heterogenous and various subtypes have been recently described in other tumor entities. Most likely these subtypes rather represent different activation states and have the capacity to interconvert, however, their precise functional role is unknown. Thus, a detailed mechanistic understanding about the cancer-stromal cross-talk as well as the stromal plasticity in CRC, particularly during late tumor stages and the relevance for metastasis development is lacking. Here we aim to perform well-defined hypothesis driven approaches to characterize the plasticity of both tumor and stromal cells and to develop innovative tools that will allow the functional analysis of distinct cell types in the stroma of primary tumors as well as in the pre-metastatic niche in the liver. This will be complemented by unbiased in vivo screens to identify novel pathways involved in plasticity of tumor epithelia and hepatocytes contributing to metastasis formation. Collectively, the combination of these comprehensive approaches that are based on sophisticated novel in vivo models as well as functional analysis of patient samples will ultimately aid the development of novel therapeutic strategies for late-stage CRC patients.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores